한글목차

콘드로이틴 황산 시장은 2025년에는 13억 2,760만 달러, 2032년에는 16억 4,390만 달러에 이를 것으로 예측되고, 2025-2032년까지의 연평균 성장률(CAGR)은 3.1%를 보일 것으로 예측됩니다.

콘드로이틴 황산은 건강한 연골, 뼈, 결합 조직의 촉진에 중요한 역할을 하는 중요한 분자입니다. 이 질병의 발생은 노화, 유전, 식생활의 혼란, 비만 등 여러 요인이 관련되어 있습니다.

시장 역학

세계의 콘드로이틴 황산 시장은 영양 보조 식품에 대한 수요 증가에 따라 성장하고 있습니다. 견인하는 또 다른 요인은 안구건조증의 치료에 도움이 되는 안약의 성분으로서 콘드로이틴 황산염의 사용이 증가하고 있는 것입니다. 또한, 성장을 가속하고 스트레스를 경감하기 위해, 동물사료에의 첨가물로서도 일반적입니다.

반면 원료 가격 변동은 시장 성장을 제한할 것으로 예측됩니다.

본 조사의 주요 특징

• 본 보고서에서는 세계의 콘드로이틴 황산 시장을 상세하게 분석하여 2024년을 기준연도로 한 예측기간 2025-2032년 시장 규모와 복합연간 성장률(CAGR%)을 제공합니다.
• 또, 다양한 부문에 걸친 잠재적인 수익 기회를 밝혀, 이 시장의 매력적인 투자 제안의 매트릭스에 대해서 해설했습니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품의 상시나 승인, 시장 동향, 지역에 의한 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 고찰도 제공합니다.
• 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등의 파라미터에 근거해, 세계의 콘드로이틴 황산 시장의 주요 기업 프로파일을 제공합니다.
• 본 보고서로부터 통찰에 의해 마케팅 담당자나 기업의 경영진은 장래의 제품 발매, 유형 업, 시장 확대, 마케팅 전술에 관한 정보에 근거한 의사 결정을 실시할 수 있습니다.
• 콘드로이틴 황산 세계 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통 업체, 신규 참가자, 재무 분석가 등이 산업의 다양한 이해 관계자에 대응하고 있습니다.
• 이해 관계자는 세계의 콘드로이틴 황산 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사 결정이 용이해집니다.

목차

제1장 조사의 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map (COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 골관절염의 유병률 증가
  • 원료 가격의 변동
  • 확대하는 제약산업
• 영향 분석
• 규제 시나리오
• 제품 출시/승인
• PEST 분석
• Porter's Five Forces 분석
• 합병과 인수 시나리오

제4장 세계의 콘드로이틴 황산 시장, 코로나 바이러스(COVID-19) 팬데믹의 영향

• COVID-19 역학
• 공급측과 수요측의 분석
• 경제에 미치는 영향

제5장 세계의 콘드로이틴 황산 시장, 공급원별, 2020-2032년

• 소개
• 소
• 영양보조식품
• 의약품
• 동물사료
• 퍼스널케어&화장품
• 기타
• 돼지
• 영양보조식품
• 의약품
• 동물사료
• 퍼스널케어&화장품
• 기타
• 가금
• 상어
• 합성

제6장 세계의 콘드로이틴 황산 시장, 지역별, 2020-2032년

• 소개
• 북미
• 유럽
• 아시아태평양
• 중남미
• 중동
• 아프리카

제7장 경쟁 구도

• TSI Group Ltd.
• Qingdao Wan Toulmin Biological Products Co., Ltd
• HeBei SanXin Industrial Group
• Bioiberica SAU
• Sigma-Aldrich, Inc.
• Sino Siam BIoTechnique Company Limited
• Bio-gen Extracts Private Limited
• SEIKAGAKU CORPORATION
• BRF
• ZPD

제8장 섹션

• 조사 방법
• 출판사에 대해

영문목차

Chondroitin Sulfate Market is estimated to be valued at USD 1,327.6 Mn in 2025 and is expected to reach USD 1,643.9 Mn by 2032, growing at a compound annual growth rate (CAGR) of 3.1% from 2025 to 2032.

Chondroitin sulfate is an important molecule that plays a key role in promoting healthy cartilage, bones, and connective tissues. It is used in the treatment of various skeletal conditions, such as osteoarthritis. Osteoarthritis is a painful condition, which leads to inflammation and stiffness of joints. Several factors are responsible for the emergence of the disease, including age, genetics, poor diet, and obesity. Chondroitin sulfate is widely used as a natural remedy to treat osteoarthritis. Moreover, it also acts as an anti-inflammatory agent.

Market Dynamics:

The global chondroitin sulfate market is growing on the account of increasing demand for dietary supplements. This is mainly due to the increase in the aging population, which makes them more susceptible to bone-related diseases such as osteoarthritis. Another factor driving the market is the growing use of chondroitin sulfate as an ingredient in eye drops, which helps in treating dry eyes. In addition, it is a common additive in animal feed to enhance growth and reduce stress.

On the other hand, fluctuating price of raw materials is expected to restrict the market growth.

Key features of the study:

• This report provides in-depth analysis of the global chondroitin sulfate market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global chondroitin sulfate market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include TSI Group Ltd., Qingdao Wan Toulmin Biological Products Co., Ltd, HeBei SanXin Industrial Group, Bioiberica S.A.U., Sigma-Aldrich, Inc., Sino Siam Biotechnique Company Limited, Bio-gen Extracts Private Limited, SEIKAGAKU CORPORATION, BRF, and ZPD
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global chondroitin sulfate market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global chondroitin sulfate market

Detailed Segmentation:

• Global Chondroitin Sulfate Market, By Source
  • Bovine
  • Nutraceuticals
  • Pharmaceuticals
  • Animal Feed
  • Personal Care & Cosmetics
  • Others
  • Swine
  • Nutraceuticals
  • Pharmaceuticals
  • Animal Feed
  • Personal Care & Cosmetics
  • Others
  • Poultry
  • Shark
  • Synthetic
• Global Chondroitin Sulfate Market, By Region
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles
  • TSI Group Ltd.
  • Qingdao Wan Toulmin Biological Products Co., Ltd
  • HeBei SanXin Industrial Group
  • Bioiberica S.A.U.
  • Sigma-Aldrich, Inc.
  • Sino Siam Biotechnique Company Limited
  • Bio-gen Extracts Private Limited
  • SEIKAGAKU CORPORATION
  • BRF
  • ZPD

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Source
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Growing prevalence of osteoarthritis
  • Volatile price of raw materials
  • Expanding pharmaceutical industry
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Chondroitin Sulfate Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Chondroitin Sulfate Market, By Source, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Bovine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Nutraceuticals
• Pharmaceuticals
• Animal Feed
• Personal Care & Cosmetics
• Others
• Swine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Nutraceuticals
• Pharmaceuticals
• Animal Feed
• Personal Care & Cosmetics
• Others
• Poultry
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
• Shark
• Synthetic

6. Global Chondroitin Sulfate Market, By Region, 2020-2032, (US$ Mn)

• Introduction
  • Market Share Analysis, By Country, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Country 2020-2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Mn)
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Mn)
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Mn)
• Central and South America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Mn)
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Mn)
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Mn)

7. Competitive Landscape

• TSI Group Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Qingdao Wan Toulmin Biological Products Co., Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• HeBei SanXin Industrial Group
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Bioiberica S.A.U.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Sigma-Aldrich, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Sino Siam Biotechnique Company Limited
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Bio-gen Extracts Private Limited
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• SEIKAGAKU CORPORATION
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• BRF
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• ZPD
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

8. Section

• Research Methodology
• About us